Cytosorbents Corporation
Cytosorbents Corporation (CTSO) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · CTSO · as of Jun 9, 2026
Key Statistics
Explore Cytosorbents Corporation Data
ctso stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 13 · Buy rate: 92.3%
Competitors & Peers
ctso competitorsCTSO
BDMD
BDSX
ECOR
ICCM
MDAIStock Performance
Full HistoryAbout Cytosorbents Corporation
Cytosorbents Corporation specializes in creating and bringing to market innovative medical devices. Their core expertise lies in a unique blood purification platform, built upon a proprietary adsorben…
what is cytosorbents corporation · ctso stock overview · cytosorbents corporation company profile · who is cytosorbents corporation ceo · ctso NASDAQ · cytosorbents corporation headquarters · cytosorbents corporation business segments
About Stock Overview & Key Data
Cytosorbents Corporation (CTSO) is a Healthcare company in the Medical - Devices industry, listed on NASDAQ since Aug 8, 2006. As of the latest trading session, CTSO stock price is $0.41, with a market capitalization of $26.0M. The stock has returned -61.65% over the past 12 months and -35.20% year-to-date.
According to 13 Wall Street analysts, the consensus rating for Cytosorbents Corporation stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, Cytosorbents Corporation reported revenue of $37.1M and net income of -$8.2M. For detailed data — including Cytosorbents Corporation revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Cytosorbents Corporation (CTSO) stock price is $0.41. The stock is traded on NASDAQ under the ticker symbol CTSO. The 52-week range is $0.41 – $1.39.